Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells.

Xanthine oxidoreductase (XOR) is a key enzyme in degradation of DNA and RNA, and has previously been shown to be decreased in aggressive breast and gastric cancer. In this study, XOR expression was assessed in tissue microarray specimens of 478 patients with colorectal cancer and related to clinical parameters. In addition, we performed in vitro studies of XOR activity, protein and mRNA in colon cancer cells (Caco-2). Results from the tissue expression analyses show that XOR was decreased in 62% and undetectable in 22% of the tumours as compared to normal tissue. Loss of XOR was associated with poor grade of differentiation (p=0.006) and advanced Dukes stage (p=0.03). In multivariate survival analysis, XOR was a prognostic factor (p=0.008), independent of Dukes stage, histological grade, age and tumour location. The in vitro analyses show that XOR is not measurable in undifferentiated Caco-2 cells, but appears and increases with differentiation. We conclude that XOR expression is associated with histological grade of differentiation and extent of disease in colorectal cancer, and it provides significant prognostic information independently of established factors.

[1]  Daniel F Hayes,et al.  ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  N. Linder,et al.  Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer , 2006, Journal of Clinical Pathology.

[3]  K. Raivio,et al.  Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions. , 2003, American journal of physiology. Cell physiology.

[4]  H. Morris,et al.  Imbalance of purine metabolism in hepatomas of different growth rates as expressed in behavior of xanthine oxidase (EC 1.2.3.2). , 1976, Cancer research.

[5]  J. Eble,et al.  Biochemical programs of slowly and rapidly growing human colon carcinoma xenografts. , 1981, Cancer research.

[6]  J. Hoidal,et al.  Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). , 1996, Genomics.

[7]  Sakai Osamu,et al.  Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): Structural analysis of the protein and chromosomal location of the gene , 1993 .

[8]  U. Al-Khalidi,et al.  The species distribution of xanthine oxidase. , 1965, The Biochemical journal.

[9]  M. Pinto,et al.  Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture , 1983 .

[10]  G. Trugnan,et al.  Monensin inhibits the expression of sucrase‐isomaltase in Caco‐2 cells at the mRNA level , 1988, FEBS letters.

[11]  K. Raivio,et al.  Nuclear factor Y activates the human xanthine oxidoreductase gene promoter , 2000, FEBS letters.

[12]  R. Lewin,et al.  Xanthine Oxidase Activity during Mammary Carcinogenesis in Mice , 1957, Nature.

[13]  E. Rings,et al.  Lactase and sucrase-isomaltase gene expression during Caco-2 cell differentiation. , 1995, The Biochemical journal.

[14]  K. Raivio,et al.  Cellular expression of xanthine oxidoreductase protein in normal human tissues. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[15]  K. Raivio,et al.  Down-Regulated Xanthine Oxidoreductase Is a Feature of Aggressive Breast Cancer , 2005, Clinical Cancer Research.

[16]  K. Raivio,et al.  Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[17]  A. Dahlqvist,et al.  A one-step ultramicro method for the assay of intestinal disaccharidases. , 1966, Analytical biochemistry.

[18]  A. Palotie,et al.  The human gene for xanthine dehydrogenase (XDH) is localized on chromosome band 2q22. , 1995, Cytogenetics and cell genetics.

[19]  H. Kizaki,et al.  Colon tumor: enzymology of the neoplastic program. , 1978, Life sciences.

[20]  K. Raivio,et al.  Regulation of xanthine oxidoreductase by intracellular iron. , 2002, American journal of physiology. Cell physiology.

[21]  K. Raivio,et al.  Cloning and expression in vitro of human xanthine dehydrogenase/oxidase. , 1996, The Biochemical journal.

[22]  Takeshi Nishino,et al.  Mammalian xanthine oxidoreductase – mechanism of transition from xanthine dehydrogenase to xanthine oxidase , 2008, The FEBS journal.

[23]  M. Capecchi,et al.  The housekeeping gene xanthine oxidoreductase is necessary for milk fat droplet enveloping and secretion: gene sharing in the lactating mammary gland. , 2002, Genes & development.

[24]  L. Aaltonen,et al.  Pathology and genetics of tumours of the digestive system , 2000 .

[25]  G. Weber,et al.  Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas. , 1986, Cancer research.

[26]  J. Repine,et al.  Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. C. Faniello,et al.  Transcription factor NF-Y regulates differentiation of CaCo-2 cells. , 2002, Archives of biochemistry and biophysics.